Inhibition of Erythropoiesis by a Factor Present in the Plasma of Patients with Erythroblastopenia

JEPSON, JOANNE H.; LOWENSTEIN, LOUIS

doi:10.1182/blood.V27.4.425.425

JOANNE H. JEPSON, M.D,

JOANNE H. JEPSON, M.D

Hematology Fellow, Royal Victoria Hospital, and Lecturer in Experimental Medicine.

1Hematology Division, Department of Medicine, Royal Victoria Hospital and the McGill University Clinic, Montreal, Quebec, Canada.

2McGill University, Montreal.

Search for other works by this author on:

This Site

PubMed

Google Scholar

LOUIS LOWENSTEIN, M.D.

Physician, Royal Victoria Hospital, and Associate Professor

1Hematology Division, Department of Medicine, Royal Victoria Hospital and the McGill University Clinic, Montreal, Quebec, Canada.

3Medicine and Clinical Medicine, McGill University, Montreal.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Blood (1966) 27 (4): 425–434.

https://doi.org/10.1182/blood.V27.4.425.425

Abstract

An erythropoietic inhibitor was found in the plasma of each of two patients with erythroblastopenia. Because these plasmas exhibited similar biological behavior to that of antisera to ESF, it is postulated that the inhibitory effect of these plasmas may be due to the formation of antibody directed against ESF.

This content is only available as a PDF.

1966

Inhibition of Erythropoiesis by a Factor Present in the Plasma of Patients with Erythroblastopenia

Abstract

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology

Inhibition of Erythropoiesis by a Factor Present in the Plasma of Patients with Erythroblastopenia

Abstract

Contents

Data & Figures

Supplemental data

References

Related

Related

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only